Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
dc.contributor.author | Lenk, Guy M. | |
dc.contributor.author | Jafar‐nejad, Paymaan | |
dc.contributor.author | Hill, Sophie F. | |
dc.contributor.author | Huffman, Lucas D. | |
dc.contributor.author | Smolen, Corrine E. | |
dc.contributor.author | Wagnon, Jacy L. | |
dc.contributor.author | Petit, Hayley | |
dc.contributor.author | Yu, Wenxi | |
dc.contributor.author | Ziobro, Julie | |
dc.contributor.author | Bhatia, Kritika | |
dc.contributor.author | Parent, Jack | |
dc.contributor.author | Giger, Roman J. | |
dc.contributor.author | Rigo, Frank | |
dc.contributor.author | Meisler, Miriam H. | |
dc.date.accessioned | 2020-03-17T18:29:37Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2020-03-17T18:29:37Z | |
dc.date.issued | 2020-03 | |
dc.identifier.citation | Lenk, Guy M.; Jafar‐nejad, Paymaan ; Hill, Sophie F.; Huffman, Lucas D.; Smolen, Corrine E.; Wagnon, Jacy L.; Petit, Hayley; Yu, Wenxi; Ziobro, Julie; Bhatia, Kritika; Parent, Jack; Giger, Roman J.; Rigo, Frank; Meisler, Miriam H. (2020). "Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome." Annals of Neurology 87(3): 339-346. | |
dc.identifier.issn | 0364-5134 | |
dc.identifier.issn | 1531-8249 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/154348 | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.title | Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Psychiatry | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154348/1/ana25676.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154348/2/ana25676_am.pdf | |
dc.identifier.doi | 10.1002/ana.25676 | |
dc.identifier.source | Annals of Neurology | |
dc.identifier.citedreference | Kearney JA, Buchner DA, de Haan G, et al. Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Nav1.6). Hum Mol Genet 2002; 11: 2765 â 2775. | |
dc.identifier.citedreference | Wagnon JL, Barker BS, Hounshell JA, et al. Pathogenic mechanisms of recurrent epileptogenic mutations of SCN8A in epileptic encephalopathy. Ann Clin Transl Neurol 2016; 3: 114 â 123. | |
dc.identifier.citedreference | Wagnon J, Meisler MH. Recurrent and nonâ recurrent mutations of SCN8A in epileptic encephalopathy. Front Neurol 2015; 6: 104. | |
dc.identifier.citedreference | Liu Y, Schubert J, Sonnenberg L, et al. Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability. Brain 2019; 142: 376 â 390. | |
dc.identifier.citedreference | Buntonâ Stasyshyn RKA, Wagnon JL, Wengert ER, et al. Prominent role of forebrain excitatory neurons in SCN8A encephalopathy. Brain 2019; 142: 362 â 375. | |
dc.identifier.citedreference | Southwell AL, Kordasiewicz HB, Langbehn D, et al. Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease. Sci Transl Med 2018; 10: eaar3959. | |
dc.identifier.citedreference | McCampbell A, Cole T, Wegener AJ, et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Invest 2018; 128: 3558 â 3567. | |
dc.identifier.citedreference | Bennett CF. Therapeutic antisense oligonucleotides are coming of age. Annu Rev Med 2019; 70: 307 â 321. | |
dc.identifier.citedreference | Roovers J, De Jonghe P, Weckhuysen S. The therapeutic potential of RNA regulation in neurological disorders. Expert Opin Ther Targets 2018; 22: 1017 â 1028. | |
dc.identifier.citedreference | Bennett CF, Krainer AR, Cleveland D. Antisense oligonucleotide therapies for neurodegenerative disorders. Ann Rev Neurosci 2019; 42: 385 â 406. | |
dc.identifier.citedreference | Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantileâ onset spinal muscular atrophy. N Engl J Med 2017; 377: 1723 â 1732. | |
dc.identifier.citedreference | Miller AR, Hawkins NA, McCollom CE, Kearney JA. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome. Genes Brain Behav 2014; 13: 163 â 172. | |
dc.identifier.citedreference | Swayze EE, Siwkowski AM, Wancewicz EV, et al. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res 2007; 35: 687 â 700. | |
dc.identifier.citedreference | Becker LA, Huang B, Bieri G, et al. Therapeutic reduction of ataxinâ 2 extends lifespan and reduces pathology in TDPâ 43 mice. Nature 2017; 544: 367 â 371. | |
dc.identifier.citedreference | Duan Y, Wang SH, Song J, et al. Semaphorin 5A inhibits synaptogenesis in early postnatalâ and adultâ born hippocampal dentate granule cells. Elife 2014; 3: e04390. | |
dc.identifier.citedreference | Schmittgen TD, Livak KJ. Analyzing realâ time PCR data by the comparative CT method. Nat Protoc 2008; 3: 1101 â 1108. | |
dc.identifier.citedreference | Wagnon JL, Korn MJ, Parent R, et al. Convulsive seizures and SUDEP in a mouse model of SCN8A related epileptic encephalopathy. Human Molec Genet 2015; 24: 506 â 515. | |
dc.identifier.citedreference | Burgess DL, Kohrman DC, Galt J, et al. Mutation of a new sodium channel gene, Scn8a, in the mouse mutant ’motor endplate disease’. Nat Genet 1995; 10: 461 â 465. | |
dc.identifier.citedreference | Sprunger LK, Escayg A, Tallaksenâ Greene S, et al. Dystonia associated with mutation of the neuronal sodium channel Scn8a and identification of the modifier locus Scnm1 on mouse chromosome 3. Hum Mol Genet 1999; 8: 471 â 479. | |
dc.identifier.citedreference | McKinney BC, Chow CY, Meisler MH, Murphy GG. Exaggerated emotional behavior in mice heterozygous for the sodium channel Scn8a (Na(v)1.6). Genes Brain Behav 2008; 7: 629 â 638. | |
dc.identifier.citedreference | Wagnon JL, Barker BS, Ottolini M, et al. Lossâ ofâ function variants of SCN8A in intellectual disability without seizures. Neurol Genet 2017; 3: e170. | |
dc.identifier.citedreference | Møller R, Wengert ER, Tronhjem CE, et al. Biallelic variants of SCN8A with reduced channel activity in two families with developmental and epileptic encephalopathy. Epilepsia 2019; 60: 2277 â 2285. | |
dc.identifier.citedreference | Guyenet SJ, Furrer SA, Damian VM, et al. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J Vis Exp 2010; 39: 1787. | |
dc.identifier.citedreference | Isom LL. Is targeting of compensatory ion channel gene expression a viable therapeutic strategy for Dravet syndrome? Epilepsy Curr 2019; 19: 193 â 195. | |
dc.identifier.citedreference | Wong JC, Makinson CD, Lamar T, et al. Selective targeting of Scn8a prevents seizure development in a mouse model of mesial temporal lobe epilepsy. Sci Rep 2018; 8: 126. | |
dc.identifier.citedreference | Martin MS, Tang B, Papale LA, et al. The voltageâ gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy. Hum Mol Genet 2007; 16: 2892 â 2899. | |
dc.identifier.citedreference | Favero M, Sotuyo NP, Lopez E, et al. A transient developmental window of fastâ spiking interneuron dysfunction in a mouse model of Dravet syndrome. J Neurosci 2018; 38: 7912 â 7927. | |
dc.identifier.citedreference | Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005â 2009. Epilepsia 2010; 51: 676 â 685. | |
dc.identifier.citedreference | Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 512 â 521. | |
dc.identifier.citedreference | Meisler MH, Kearney KJ. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 2005; 115: 2010 â 2017. | |
dc.identifier.citedreference | Larsen J, Carvill GL, Gardella E, et al. The phenotypic spectrum of SCN8A encephalopathy. Neurology 2015; 84: 480 â 489. | |
dc.identifier.citedreference | Lindy AS, Stosser MB, Butler E, et al. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders. Epilepsia 2018; 59: 1062 â 1071. | |
dc.identifier.citedreference | Meisler MH, Helman G, Hammer MF, et al. SCN8A encephalopathy: research progress and prospects. Epilepsia 2016; 57: 1027 â 1035. | |
dc.identifier.citedreference | Gardella E, Marini C, Trivisano M, et al. The phenotype of SCN8A developmental and epileptic encephalopathy. Neurology 2018; 91: e1112 â e1124. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.